Enbrel 50 MG/ML sureclickml
Ended Awarded
- Contract number
- SPE2DB25FQVDT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $14,388
Award facts
- Contract value 100% obligated
- $14,387.79 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $14,387.79 to AmerisourceBergen Drug Corp for ENBREL 50 MG/ML SureClick auto-injector pens, with an ultimate completion date of August 28, 2025. This is a firm fixed price delivery order with no set-aside designation, issued competitively under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ENBREL (etanercept) is a biologic immunosuppressant used primarily for treating rheumatoid arthritis and other inflammatory conditions, representing the type of specialized pharmaceutical products that support military healthcare systems.
This delivery order is a child contract under AmerisourceBergen's $999.999 billion Pharmaceutical Prime Vendor Global Program IDC with DLA (contract number SPE2DX), which extends through December 2026 and serves as a comprehensive global pharmaceutical support vehicle for military healthcare worldwide. AmerisourceBergen's federal contract portfolio demonstrates significant capability in supplying brand-name and generic medications, specialty pharmaceuticals, vaccines, and medical devices across multiple therapeutic domains to support the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The DLA is planning to establish next-generation Pharmaceutical Prime Vendor Global Program Generation V contracts with multiple regional awards, indicating AmerisourceBergen's continued strategic role in federal pharmaceutical procurement.
Quick answers
Who was awarded contract SPE2DB25FQVDT?
SPE2DB25FQVDT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 27, 2025.
How much is contract SPE2DB25FQVDT worth?
The government has obligated $14,388 on SPE2DB25FQVDT.
Is contract SPE2DB25FQVDT an order under another contract?
Yes. SPE2DB25FQVDT is a delivery order under SPE2DB25D3001, an indefinite delivery contract.
Was contract SPE2DB25FQVDT competed?
The extent of competition for SPE2DB25FQVDT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award